23andMe gets FDA clearance for prostate cancer risk test – The Verge

Share this Story

The Food and Drug Administration cleared a prostate cancer risk test from 23andMe that looks for a mutation linked to the disease. It’s the third cancer risk test from the company.

Author: Nicole Wetsman

READ MORE